Clinical Trial Update: Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating adoptive family-matched cytotoxic T lymphocytes plus standard of care versus standard of care alone for refractory CMV or ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection

Drugs mentioned

• Family-matched cytotoxic T lymphocytes (CTLs) therapy (adoptive cytotoxic T lymphocyte therapy)
• Standard of Care (SOC) (standard of care)

Snippet

Sponsor: New York Medical College | Conditions: CMV, AdV Infection | Phase 3 | Status: NOT_YET_RECRUITING